![]()
|
|
||||||||
J Biol Chem, Vol. 273, Issue 12, 6878-6884, March 20, 1998
From the Section on Growth Factors, NICHD and the ¶ Laboratory
of Molecular Biology, Division of Basic Sciences, NCI, National
Institutes of Health, Bethesda, Maryland 20892
Treatment of PC12 cells with nerve growth factor
leads to a decrease in the number of epidermal growth factor receptors
on the cell membrane. The mRNA for the epidermal growth factor
receptor decreases in a comparable fashion. This decrease appears due
to a decrease in the transcription of the epidermal growth factor receptor gene because first, there is no difference in the stability of
the epidermal growth factor receptor mRNA, second, newly
transcribed epidermal growth factor receptor mRNA is decreased in
nerve growth factor-differentiated cells, and third, constructs
containing the promoter region of the epidermal growth factor receptor
gene are transcribed much less readily in nerve growth
factor-differentiated cells than in untreated cells. The decreases in
mRNA are not seen in the p140trk-deficient variant PC12nnr5
cells nor in cells containing either dominant-negative Ras or
dominant-negative Src. Treatment with nerve growth factor also
increases the cellular content of GCF2, a putative transcription factor
inhibitory for the transcription of the epidermal growth factor
receptor gene. The increase in GCF2, like the decrease in the epidermal
growth factor receptor mRNA, is not seen in PC12nnr5 cells nor in
cells expressing either dominant-negative Ras or dominant-negative Src.
The results suggest that nerve growth factor-induced down-regulation of
the epidermal growth factor receptor is under transcriptional control,
is p140trk-, Ras-, and Src-dependent, and may
involve transcriptional repression by GCF2.
This article has been cited by other articles:
![]() |
M. Shibutani, N. Takahashi, T. Kobayashi, C. Uneyama, N. Masutomi, A. Nishikawa, and M. Hirose Molecular profiling of genes up-regulated during promotion by phenobarbital treatment in a medium-term rat liver bioassay Carcinogenesis, June 1, 2002; 23(6): 1047 - 1055. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Olivi, J. Sisk, and J. Bressler Involvement of DMT1 in uptake of Cd in MDCK cells: role of protein kinase C Am J Physiol Cell Physiol, September 1, 2001; 281(3): C793 - C800. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-W. Liu, Y. Katagiri, H. Jiang, L.-J. Gong, L.-Y. Guo, M. Shibutani, A. C. Johnson, and G. Guroff Cloning and Characterization of the Promoter Region of the Rat Epidermal Growth Factor Receptor Gene and Its Transcriptional Regulation by Nerve Growth Factor in PC12 Cells J. Biol. Chem., March 15, 2000; 275(10): 7280 - 7288. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Lillien and H Raphael BMP and FGF regulate the development of EGF-responsive neural progenitor cells Development, January 11, 2000; 127(22): 4993 - 5005. [Abstract] [PDF] |
||||
![]() |
R. L. Malek, Z. Nie, V. Ramkumar, and N. H. Lee Adenosine A2A Receptor mRNA Regulation by Nerve Growth Factor Is TrkA-, Src-, and Ras-dependent via Extracellular Regulated Kinase and Stress-activated Protein Kinase/c-Jun NH2-terminal Kinase J. Biol. Chem., December 10, 1999; 274(50): 35499 - 35504. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Khachigian, F. S. Santiago, L. A. Rafty, O. L.-W. Chan, G. J. Delbridge, A. Bobik, T. Collins, and A. C. Johnson GC Factor 2 Represses Platelet-Derived Growth Factor A-Chain Gene Transcription and Is Itself Induced by Arterial Injury Circ. Res., June 11, 1999; 84(11): 1258 - 1267. [Abstract] [Full Text] |
||||
![]() |
E. M. Mills, K. Takeda, Z.-X. Yu, V. Ferrans, Y. Katagiri, H. Jiang, M. C. Lavigne, T. L. Leto, and G. Guroff Nerve Growth Factor Treatment Prevents the Increase in Superoxide Produced by Epidermal Growth Factor in PC12 Cells J. Biol. Chem., August 28, 1998; 273(35): 22165 - 22168. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Reed, H. Yamazaki, J. D. Kaufman, Y. Rubinstein, B. Murphy, and A. C. Johnson Molecular Cloning and Characterization of a Transcription Regulator with Homology to GC-binding Factor J. Biol. Chem., August 21, 1998; 273(34): 21594 - 21602. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-W. Liu, L.-J. Gong, L.-Y. Guo, Y. Katagiri, H. Jiang, Z.-Y. Wang, A. C. Johnson, and G. Guroff The Wilms' Tumor Gene Product WT1 Mediates the Down-regulation of the Rat Epidermal Growth Factor Receptor by Nerve Growth Factor in PC12 Cells J. Biol. Chem., February 9, 2001; 276(7): 5068 - 5073. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |